PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex

PureTech Health has spied an opportunity to improve on Jazz Pharmaceuticals’ Epidiolex. Armed with its Glyph chemistry platform, the biotech has created an oral capsule formulation of cannabidiol (CBD) that it plans to take into the clinic late next year.